BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18814107)

  • 1. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
    Bağdatoğlu C; Bağdatoğlu OT; Muslu N; Köseoğlu A; Dağtekin A; Polat G; Dolgun H; Karataş MA
    Turk Neurosurg; 2008 Jul; 18(3):223-7. PubMed ID: 18814107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center.
    Chutpiboonwat P; Yenpinyosuk K; Sridama V; Kunjan S; Klaimukh K; Snabboon T
    Pan Afr Med J; 2020; 36():8. PubMed ID: 32550971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macroprolactinemia: new insights in hyperprolactinemia.
    Kasum M; Oreskovic S; Zec I; Jezek D; Tomic V; Gall V; Adzic G
    Biochem Med (Zagreb); 2012; 22(2):171-9. PubMed ID: 22838183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance.
    Elenkova A; Genov N; Abadzhieva Z; Kirilov G; Vasilev V; Kalinov K; Zacharieva S
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):201-5. PubMed ID: 23595795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R; Okopień B
    Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
    Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
    Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia.
    Can M; Guven B; Atmaca H; Acıkgoz S; Mungan G
    Kaohsiung J Med Sci; 2011 May; 27(5):173-6. PubMed ID: 21527183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia.
    Overgaard M; Pedersen SM
    Clin Chem Lab Med; 2017 Oct; 55(11):1744-1753. PubMed ID: 28236625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect.
    Dagdelen S; Usman A
    Minerva Endocrinol; 2010 Jun; 35(2):53-9. PubMed ID: 20595935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
    Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroprolactinemia revisited: a study on 106 patients.
    Vallette-Kasic S; Morange-Ramos I; Selim A; Gunz G; Morange S; Enjalbert A; Martin PM; Jaquet P; Brue T
    J Clin Endocrinol Metab; 2002 Feb; 87(2):581-8. PubMed ID: 11836289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F; Darendeliler F; Aygün M; Hekim N
    Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
    Suliman AM; Smith TP; Gibney J; McKenna TJ
    Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
    Cavaco B; Leite V; Santos MA; Arranhado E; Sobrinho LG
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2342-6. PubMed ID: 7629227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is idiopathic hyperprolactinemia a transitional stage toward prolactinoma?
    Pereira MC; Sobrinho LG; Afonso AM; Ferreira JM; Santos MA; Sousa MF
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):305-8. PubMed ID: 3114691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.